Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Marc S Raab Hartmut Goldschmidt Tobias Meißner Dirk Hose Anja Seckinger Anthony Ho |
| Publication date | November 1, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |